Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc. advances care for underserved neurological disorders and rare diseases. Driven by the reality that too many patients have few or no treatment options, the company focuses on therapeutic areas where no approved therapies currently exist, serving communities around the world. Its commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome, alongside a clinical pipeline that features mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis.

In its efforts to advance healthcare solutions, Acadia engages in artificial intelligence and machine learning through applied AI and generative AI capabilities. These technical functions are applied to measurably improve data processing, quality review, and programming productivity under human oversight and in compliance with regulations, standard operating procedures, and data privacy requirements.

The open roles at Acadia indicate that the company builds specialized technical teams focused on clinical data automation and programming. The available positions include senior individual contributor roles, such as the Associate Director for Clinical Data Integration and AI Programming. This specific role requires technical expertise in languages and platforms such as R, Python, SQL, APIs, and Posit to build automated pipelines, standardized data models, and dashboards. The position is structured as a remote opportunity located within the United States.